Increasing Access to LARC: Evidence Based Counseling and Clinical Practices
-
Register
- User - $40
Preventing unintended pregnancy by providing the most effective contraceptive methods without barriers is more important then ever. Long-acting reversible contraception (LARC) is the safest and most effective contraception available. The implant and IUDs also have the highest patient satisfaction and continuation rates, and yet there remain many barriers to patients accessing these contraceptive methods. We will review common barriers and how to avoid them in your practice. We will discuss how to provide patient centered counselling about LARC methods, tools to provide the most up to date evidence-based care, and how to remove operational barriers in your practice. Whether you don’t provide LARC yet and want to hone your counselling skills and are interested in free training opportunities; or you are an experienced provider of LARC and want to update your practice and learn some helpful tips and tricks-There is something for everyone in this presentation.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.50 Contact Hours; 1.50 are Pharmacology
This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 2/11/2025 to 2/10/2026. PAs should only claim credit commensurate with the extent of their participation
Expiration Date: February 10, 2026
$40
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Understand how removal of systemic barriers to LARC access can decrease disparities in unintended pregnancy
-Provide patient centered contraceptive counselling about LARC methods
-Remove unnecessary provider barriers to LARC access by using evidence-based recommendations for LARC provision
Rachael Phelps, MD
Dr. Rachael Phelps is a family planning expert who has provided contraceptive and abortion care at Planned Parenthood of Central and Western New York for 25 years, of which she served as Medical Director for 13 years. She co-led the Greater Rochester LARC Initiative and has worked in legally restrictive settings in Asia and Africa to decrease maternal mortality from unsafe abortion.
She received her medical degree from The Johns Hopkins School of Medicine. She completed a Pediatrics Residency and a Complex Family Planning Fellowship at the University of Rochester. She is currently a clinical instructor in the departments of Pediatrics and OB/GYN at the University of Rochester. She lectures nationally and internationally about the prevention of unintended pregnancy, evidence-based contraception and access to safe abortion care.
She received the Women Leaders in Medicine Award from The American Medical Student Association, the Hannah G. Solomon Humanitarian Award from the National Council of Jewish Women and was profiled in the New York Times Magazine article “The New Abortion Providers.”
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 2/11/2025 to 2/10/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid from 2/11/2025 to 2/10/2026. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Rachael Phelps, MD has disclosed:
Bayer Clinical trainer only. NO involvement w/ sales IUD Mirena/Kyleena/Skyla
Organon Clinical trainer for FDA required training program. No involvement w/sales Implant Nexplanon
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
